1. Home
  2. PASW vs GTBP Comparison

PASW vs GTBP Comparison

Compare PASW & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASW

Ping An Biomedical Co. Ltd. Ordinary Shares

HOLD

Current Price

$4.27

Market Cap

15.0M

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$5.40

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASW
GTBP
Founded
2021
1965
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0M
12.4M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
PASW
GTBP
Price
$4.27
$5.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 582.0K
42.8K
Earning Date
11-24-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.75
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.22
52 Week High
$0.77
$287.50

Technical Indicators

Market Signals
Indicator
PASW
GTBP
Relative Strength Index (RSI) 98.83 34.22
Support Level $0.14 $0.22
Resistance Level N/A $7.73
Average True Range (ATR) 0.24 0.64
MACD 0.31 0.62
Stochastic Oscillator 80.39 4.05

Price Performance

Historical Comparison
PASW
GTBP

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: